We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Resmed Inc (RMD) Com Stk USD 0.004

Sell:$243.59 Buy:$243.60 Change: $0.18 (0.07%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Sell:$243.59
Buy:$243.60
Change: $0.18 (0.07%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Sell:$243.59
Buy:$243.60
Change: $0.18 (0.07%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.

Contact details

Address:
9001 Spectrum Center Blvd
SAN DIEGO
92123-1438
United States
Telephone:
+1 (858) 7462400
Website:
https://www.resmed.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RMD
ISIN:
US7611521078
Market cap:
$35.46 billion
Shares in issue:
146.80 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Farrell
    Chairman of the Board, Chief Executive Officer
  • Brett Sandercock
    Chief Financial Officer
  • Michael Rider
    Global General Counsel, Company Secretary
  • Bobby Ghoshal
    Chief Commercial Officer - SaaS
  • Justin Leong
    Chief Product Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.